ie Sa ts eh as hi i a: i A SS it RS eS A Smt Se NS Sn Si Nh en i HE EE Se, a a AER sD SON ERNE HRI ON Nie non in ih nena” ee “ir i ih nh i eh le leport for the 105th Congress Wed, September 24, 1997 4:16pm (EDT) eer Oe, NS A EO SY AY OE mh NR ARE A a NE. ARE FE ENE SE GR RE YS FERRE he tb eR ne EAN en * Search of the Congressional Record Showing the Full Text of Each Item On 09/23/97 AND Contained in All Sections AND Attributed to Selected Members of Congress and Limited to 5.830 “kin “i ‘i i sie a tm hE OM SEE LRG Eo tn th Rit ne th AES MA ie i ee me nt ai A a En ni im ie ie is Congressional Record dated Tuesday, September 23, 1997 Senate Section Se i i ai eee ee ee ae a i i Ele AE NR A TE SS ee i ee A el ie ie RE Measure Debated by JEFFORDS (R-VT) and 3 others -~ $. 830 UNANIMOUS-CONSENT AGREEMENT [CR page $-9759, 247 lines] Attributed to JEFFORDS (R-VT) UNANIMOUS~CONSENT AGREEMENT Mr. JEFFORDS. Mr. President, I have a unanimous-consent request which I will offer. I ask unanimous consent that immediately following the cloture vote with respect to S. 830, if invoked, there be only the following time remaining in the following fashion: 4 hours equally divided between the chairman and the _ ranking minority member or their designee for use during today's session only; 4 hours equally divided between the chairman and the ranking minority member or their designee for use during the session of the Senate on Wednesday, September 24, beginning at noon. I further ask, notwithstanding rule XXII, that following the conclusion or yielding back of time, the Senate proceed to vote on S. 830, as amended, without further action or debate. a The PRESIDING OFFICER. Without objection, it is so ordered. AMENDMENT NO. 1137 The PRESIDING OFFICER. Under the previous agreement, wé now have 20 minutes equally divided on the Harkin amendment numbered 1137, 10 minutes under the control of the Senator from Iowa and 10 minutes under the control of the Senator from Tennessee. ‘The Senator from Iowa is recognized. _ Mr. HARKIN. I yield myself 5 minutes. Mr. President, there are many positive provisions in this bill that I am pleased to support. However, I am disappointed that an essential element has mot been included in this bill. A major goal of FDA reform is to ensure that the public has access to medical innovations without compromising public delay in moving to assure and improve and expand rigorous scientific review safety. But the multimillion